Premium
A novel hPirh2 splicing variant without ubiquitin protein ligase activity interacts with p53 and is down‐regulated in hepatocellular carcinoma
Author(s) -
Wu Gang,
Sun Meiqian,
Zhang Liping,
Zhou Juan,
Wang Yi,
Huo Keke
Publication year - 2010
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2010.04.075
Subject(s) - immunoprecipitation , rna splicing , hepatocellular carcinoma , ubiquitin ligase , ubiquitin , dna ligase , chemistry , uniprot , microbiology and biotechnology , biology , computational biology , cancer research , biochemistry , gene , rna
MINT‐7890105: hPirh2b (uniprotkb:Q2KN33) physically interacts (MI:0915) with p53 (uniprotkb:P04637) by anti tag coimmunoprecipitation (MI:0007)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom